The IL-1β-IL6-CRP axis constitutes a central inflammatory pathway in atherosclerosis and cardiovascular disease, where IL-1β serves as the upstream regulator that activates the NLRP3 inflammasome to induce ECs expression of adhesion molecules, thereby promoting inflammatory cell recruitment and macrophage activation. The gene discussed is IL1B; the disease is atherosclerosis.